Cerenis Therapeutics' Grant

Cerenis Therapeutics raised a round of funding on February 23, 2009. Investors include OSEO.

Cerenis Therapeutics is a biotechnology company dedicated to the discovery, development and commercialization of novel HDL therapies for the treatment of cardiovascular and metabolic diseases. Cereni…

Articles about Cerenis Therapeutics' Grant: